363 related articles for article (PubMed ID: 17929298)
1. Present status of ABO-incompatible living donor liver transplantation in Japan.
Egawa H; Teramukai S; Haga H; Tanabe M; Fukushima M; Shimazu M
Hepatology; 2008 Jan; 47(1):143-52. PubMed ID: 17929298
[TBL] [Abstract][Full Text] [Related]
2. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
Raut V; Mori A; Kaido T; Ogura Y; Taku I; Nagai K; Sasaki N; Endo K; Hata T; Yagi S; Egawa H; Uemoto S
Transplantation; 2012 Jan; 93(1):99-105. PubMed ID: 22094955
[TBL] [Abstract][Full Text] [Related]
3. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
[TBL] [Abstract][Full Text] [Related]
4. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
5. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era.
Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kang SH; Jung BH; Yoon YI; Kim N
J Hepatol; 2014 Sep; 61(3):575-82. PubMed ID: 24801413
[TBL] [Abstract][Full Text] [Related]
6. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
Egawa H; Ohmori K; Haga H; Tsuji H; Yurugi K; Miyagawa-Hayashino A; Oike F; Fukuda A; Yoshizawa J; Takada Y; Tanaka K; Maekawa T; Ozawa K; Uemoto S
Liver Transpl; 2007 Apr; 13(4):579-88. PubMed ID: 17394164
[TBL] [Abstract][Full Text] [Related]
7. Section 15. A desensitizing protocol without local graft infusion therapy and splenectomy is a safe and effective method in ABO-incompatible adult LDLT.
Song GW; Lee SG; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Park HW; Park YH; Kang SH; Jung BH
Transplantation; 2014 Apr; 97 Suppl 8():S59-66. PubMed ID: 24849837
[TBL] [Abstract][Full Text] [Related]
8. Current progress in ABO-incompatible liver transplantation.
Tanabe M; Kawachi S; Obara H; Shinoda M; Hibi T; Kitagawa Y; Wakabayashi G; Shimazu M; Kitajima M
Eur J Clin Invest; 2010 Oct; 40(10):943-9. PubMed ID: 20636381
[TBL] [Abstract][Full Text] [Related]
9. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange.
Kawagishi N; Satoh K; Enomoto Y; Akamatsu Y; Sekiguchi S; Fukumori T; Fujimori K; Satomi S
Transplant Proc; 2005 Mar; 37(2):1205-6. PubMed ID: 15848670
[TBL] [Abstract][Full Text] [Related]
10. Present status of ABO-incompatible kidney transplantation in Japan.
Takahashi K; Saito K
Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
[TBL] [Abstract][Full Text] [Related]
11. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation.
Egawa H; Oike F; Buhler L; Shapiro AM; Minamiguchi S; Haga H; Uryuhara K; Kiuchi T; Kaihara S; Tanaka K
Transplantation; 2004 Feb; 77(3):403-11. PubMed ID: 14966415
[TBL] [Abstract][Full Text] [Related]
12. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen.
Yoshizawa A; Sakamoto S; Ogawa K; Kasahara M; Uryuhara K; Oike F; Ueda M; Takada Y; Egawa H; Tanaka K
Transplant Proc; 2005 May; 37(4):1718-9. PubMed ID: 15919443
[TBL] [Abstract][Full Text] [Related]
13. Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier.
Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Kwon SW; Ko GY; Kim KW
Liver Transpl; 2010 Apr; 16(4):491-8. PubMed ID: 20222051
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of ABO-incompatible living-donor liver transplantation: a single-center experience.
Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Satomi S
J Hepatobiliary Pancreat Surg; 2009; 16(4):468-72. PubMed ID: 19333538
[TBL] [Abstract][Full Text] [Related]
16. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases.
Soejima Y; Muto J; Matono R; Ninomiya M; Ikeda T; Yoshizumi T; Uchiyama H; Ikegami T; Shirabe K; Maehara Y
Clin Transplant; 2013; 27(2):227-31. PubMed ID: 23293980
[TBL] [Abstract][Full Text] [Related]
17. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
[TBL] [Abstract][Full Text] [Related]
18. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
[TBL] [Abstract][Full Text] [Related]
19. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study.
Egawa H; Teramukai S; Haga H; Tanabe M; Mori A; Ikegami T; Kawagishi N; Ohdan H; Kasahara M; Umeshita K
Am J Transplant; 2014 Jan; 14(1):102-14. PubMed ID: 24279828
[TBL] [Abstract][Full Text] [Related]
20. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
